Blood-retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains

被引:33
作者
Stanley, AV
Wang, Y
Vinores, MA
Derevjanik, NL
Shi, A
Klein, DA
Detrick, B
Hooks, JJ
机构
[1] Johns Hopkins Univ, Sch Med, Wilmer Ophthalmol Inst, Baltimore, MD 21287 USA
[2] NEI, Immunol & Virol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA
关键词
coronavirus; blood-retinal barrier; vascular endothelial growth factor; retinopathy;
D O I
10.1016/S0165-5728(01)00374-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intraocular coronavirus inoculation results in a biphasic retinal disease in susceptible mice (BALB/c) characterized by an acute inflammatory response, followed by retinal degeneration associated with autoimmune reactivity. Resistant mice (CD-1), when similarly inoculated, only develop the early phase of the disease. Blood-retinal barrier (BRB) breakdown occurs in the early phase in both strains, coincident with the onset of inflammation. As the inflammation subsides, the extent of retinal vascular leakage is decreased, indicating that BRB breakdown in experimental coronavirus retinopathy (ECOR) is primarily due to inflammation rather than to retinal cell destruction. Vascular endothelial growth factor (VEGF) is upregulated only in susceptible mice during the secondary (retinal degeneration) phase. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 50 条
[1]  
Agresti A, 1990, CATEGORICAL DATA ANA, P100
[2]  
AULT KA, 1981, J IMMUNOL, V126, P359
[3]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[4]   Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes [J].
Chen, YS ;
Hackett, SF ;
Schoenfeld, CL ;
Vinores, MA ;
Vinores, SA ;
Campochiaro, PA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (10) :919-926
[5]   The vascular endothelial growth factor receptor Flt-1 mediates biological activities - Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis [J].
Clauss, M ;
Weich, H ;
Breier, G ;
Knies, U ;
Rockl, W ;
Waltenberger, J ;
Risau, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :17629-17634
[6]   VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION [J].
CLAUSS, M ;
GERLACH, M ;
GERLACH, H ;
BRETT, J ;
WANG, F ;
FAMILLETTI, PC ;
PAN, YCE ;
OLANDER, JV ;
CONNOLLY, DT ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1535-1545
[7]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[8]  
GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355
[9]   ADENOSINE AS AN ENDOGENOUS MEDIATOR OF HYPOXIA FOR INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RNA IN U-937 CELLS [J].
HASHIMOTO, E ;
KAGE, K ;
OGITA, T ;
NAKAOKA, T ;
MATSUOKA, R ;
KIRA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (01) :318-324
[10]   Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression [J].
Heil, M ;
Clauss, M ;
Suzuki, K ;
Buschmann, IR ;
Willuweit, A ;
Fischer, S ;
Schaper, W .
EUROPEAN JOURNAL OF CELL BIOLOGY, 2000, 79 (11) :850-857